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Background. The Vanilloid subfamily of transient receptor potential (TRPV) ion channels has been widely implicated in detecting
osmotic and mechanical stress. In the current study, we examine the functional expression of TRPV4 channels in cell volume
regulation in cells of the human collecting duct. Methods. Western blot analysis, siRNA knockdown, and microfluorimetry were
used to assess the expression and function of TRPV4 in mediating Ca2+-dependent mechanical stimulation within a novel system
of the human collecting duct (HCD). Results. Native and siRNA knockdown of TRPV4 protein expression was confirmed by
western blot analysis. Touch was used as a cell-directed surrogate for osmotic stress. Mechanical stimulation of HCD cells evoked a
transient increase in [Ca2+]i that was dependent upon thapsigargin-sensitive store release and Ca2+ influx. At 48 hrs, high glucose
and mannitol (25mM) reduced TRPV4 expression by 54% and 24%, respectively. Similar treatment doubled SGK1 expression.
Touch-evoked changes were negated following TRPV4 knockdown. Conclusion. Our data confirm expression of Ca2+-dependent
TRPV4 channels in HCD cells and suggest that a loss of expression in response to high glucose attenuates the ability of the collecting
duct to exhibit regulatory volume decreases, an eﬀect that may contribute to the pathology of fluid and electrolyte imbalance as
observed in diabetic nephropathy.
1. Introduction
Diabetic nephropathy (DN) is the leading cause of end-stage
renal disease and subsequent entry into renal replacement
programmes. Characterized by structural and functional
disturbances, patients with DN can exhibit renal hypertro-
phy, fibrosis, altered glomerular filtration rate, glomerular
hypertension, proteinuria, and systemic hypertension [1].
Maintaining cellular integrity is critical for normal cell
function, but renal epithelial cells are exposed to constant
fluctuations in filtrate flow and osmolality. Tubular cells
have developed a number of mechanisms to compensate
for cell volume changes induced by alterations in filtration
rates and osmolarity. Two such complementary mechanisms
are the serum and glucocorticoid-inducible kinase (SGK)
and the mechanosensitive transient receptor potential (TRP)
channel. Activated by cell shrinkage, SGK1 is one of the key
regulators of Na+ reabsorption and is responsible for the
insertion of the epithelial sodium channel (ENaC) into the
apical membrane of the collecting duct (reviewed in [2]). In
models of diabetic nephropathy, SGK expression is exacer-
bated [3, 4]. It has been suggested that accentuated increase
in SGK-driven Na+ reabsorption contributes to the subse-
quent development of secondary hypertension observed in
some patients with diabetic nephropathy.
The Vanilloid subfamily of TRP (TRPV) ion channels
is implicated in detecting and transducing responses to a
broad range of stimuli that include mechanical stress, heat,
and pain (reviewed in [5]). Although we have a good under-
standing of how glucose alters SGK expression and function,
as a potential counter-regulatory mechanism of SGK in the
kidney, there is only sparse data pertaining to the eﬀects of
glucose on the calcium permeable TRPV channels, known to
be activated in response to increased hypotonicity.
Mammalian TRP channels have been organised into
protein subfamilies based on sequence identity [6]. Within
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Table 1: Polymerase chain reaction (PCR) primers used to amplify TRPV4 mRNA. F: forward primer, R: reverse primer.
mRNA Primers (5′→ 3′) Direction Annealing temp Product size
TRPV4 CCCGTGAGAACACCAAGTTT
TCACTCCAGGGCATTTCTTC
F
R
58◦C 618 bp
this subfamily of related proteins, the Ca2+ permeable
TRPV4 channel is expressed abundantly in water imperme-
ant segments of the nephron, including the cortical collecting
duct [7], where it acts as a sensor for both osmolarity
and shear stress [8]. The rise in cytosolic calcium ([Ca2+]i)
that follows hypoosmotic-induced cell swelling has been
demonstrated in a number of volume-regulating cell types,
including, bronchial epithelial cells [9], chondrocytes [10],
and bladder urothelium [11]. The hypotonic activation of
TRPV4, with a concomitant rise in [Ca2+]i, has implicated
this Ca2+ permeable cation channel as a possible mediator
in cellular osmoreception in aiding cell volume recovery.
Dysregulation of TRPV4 channel functional expression may
have severe repercussions for epithelial integrity.
In the current study, we have used a novel model cell
system of the human collecting duct (HCD-cells) to confirm
expression and function of TRPV4 channels. We have
examined the eﬀect of high glucose on TRPV4 and SGK1
expression in an attempt to better elucidate the role of
these regulatory proteins in maintaining cell volume under
physical stress and thus preventing the development of
secondary hypertension which is often observed in DN.
2. Materials and Methods
2.1. Cell Culture. HCD cells were derived from normal
human kidney cortex and immortalized with SV-40 virus.
Clones were selected using the monoclonal antibody,
Ab272, which specifically recognizes collecting duct prin-
cipal cells. HCD cells (passages 18–30) were maintained
in DMEM/Hams F-12 medium (GIBCO, Invitrogen), sup-
plemented with 2% fetal calf serum (FCS), glutamine
(2mmol/L), 15mmol/L HEPES, transferrin (5 μg/mL),
Na2SeO3 (5 ng/mL), insulin (5 μg/mL), and dexamethasone
(5 × 10−8 M). Cells were grown at 37◦C in a humidified
atmosphere of 5% CO2 in air. Prior to treatment, cells
were cultured in DMEM/Hams F-12 low glucose (5mM)
for 48 hours. Basal (5mM) glucose and high glucose
(25mM) culture media was generated as described previ-
ously [12]. For calcium experiments, cells were seeded onto
3-Aminopropyltriethoxysilane-(APES-) (Sigma, Poole, UK)
treated coverslips and used within 1 day of plating. In all
experiments, cells were serum starved overnight before ago-
nist stimulation. For immunocytochemistry and microfluo-
rimetry experiments, cells were seeded onto 3-Aminopropyl-
triethoxysilane (APES) (Sigma, Poole, UK) treated coverslips
and used within 2 days of plating.
2.2. Analysis of mRNA Expression. RNA was prepared from
80% confluent HCD cells by acid-guanidinium extraction
[13] using a genelute mammalian total RNA miniprep
kit (Sigma) following the manufactures instructions. Com-
plementary DNA was synthesized by reverse transcription
using a Promega Reverse Transcription System following an
adapted method. Briefly, 1 μg of total RNA and 0.5 μg of
random hexamers, in a final volume of 11 μL, were incubated
at 70◦C for 5 minutes, and then allowed to cool slowly to
25◦C. Primer extension was then performed at 37◦C for 60
minutes following the addition of 1x (final concentration)
reaction buﬀer, containing 50mmol/L Tris-HCl (pH 8.3),
50mmol/L KCl, 10mmol/LMgCl2, 10mmol/L dithiothreitol
and 0.5mmol/L spermidine, 1mmol/L (final concentration)
of each dNTP, 40U of rRNAsin ribonuclease inhibitor, and
15U of AMV reverse transcriptase in a final volume of 20 μL.
The RT mixture was heated to 95◦C for 5 minutes, then 4◦C
for 5 minutes. An aliquot of 4 μL was used in subsequent
polymerase chain reaction (PCR) reactions.
2.3. PCR Amplification of cDNAs. Amplification of specific
cDNAs was carried out using the primers listed in Table 1.
PCR reactions (20 μL) were set up containing 1.5mmol/L
MgCl2, 0.2mmol/L of each dNTP, 0.5 μM of each primer,
and 1U of Taq DNA polymerase (Bioline). Amplification
of samples was performed using an initial denaturation step
of 95◦C (5 minutes) followed by either 34 (TRPV4) or 35
(SGK1) cycles consisting of one minute of denaturing at
95◦C, one minute of annealing at the required temperature
(Table 1), and a one-minute extension at 72◦C. A final
elongation step of 72◦C for seven minutes was included in
all PCR amplifications.
2.4. Analysis of Protein Expression. The preparation of
cytosolic proteins and their subsequent separation by gel
electrophoresis and electroblotting onto Immobilon P mem-
brane (Millipore, Watford, UK) were as described previously
[14]. Briefly, proteins (5 μg) were separated by sodium dode-
cyl sulphate (SDS) polyacrylamide gel electrophoresis (4.5%
stacking gel, 7.5% or 10% resolving gel) at 200 volts for 50
minutes in electrophoresis buﬀer containing 25mmol/L Tris,
192mmol/L glycine, and 0.1% (wt/vol) SDS. Proteins were
transferred onto Immobilin P membrane in transfer buﬀer
(25mmol/LTris, 192mmol/L glycine, and 20% (vol/vol)
methanol) for 1 hour at 100 volts; 4◦C. Following protein
transfer, membranes were blocked in PBS-T (PBS plus 0.1%
Tween-20) containing 20% (wt/vol) nonfat milk powder
(Marvel, Premier Brands, Staﬀord, UK) for 1 hour at 25◦C
and then washed with PBS-T for 15 minutes. Filters were
analyzed with specific polyclonal antibodies against human
TRPV4 (The Binding Site Ltd., Birmingham, UK) diluted
in PBS-T (0.05%) at 1 : 1000 or SGK (The Binding Site
Ltd., Birmingham, UK) diluted in PBS-T (0.05%) at 1 : 3000.
After three 10-minute washes in PBS-T, the membranes
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were incubated with the secondary antibody horseradish
peroxidase-conjugated antisheep (diluted 1 : 30,000) in PBS-
T (0.05%) for 60 minutes at 25◦C followed by three 10-
minute washes in PBS-T. Specific proteins were detected
using ECL detection reagent chemiluminescence system
(Amersham Biosciences) and were visualized after exposure
of membranes to X-ray film for 1–10 minutes. Control
experiments were included where primary antibody was
omitted, and filters were exposed to secondary antibody and
ECL detection.
2.5. Knockdown of TRPV4 Expression. Cells were allowed to
grow to 40% confluence in 6 well plates or APES-treated
coverslips. Knock-down of TRPV4 expression was achieved
by two diﬀerent siRNA protocols.
(1) Transfection of cells with a TRPV4 specific siRNA
(Invitrogen). Transfection of siRNAs was carried out using
lipofectamine (Invitrogen) following manufacturers instruc-
tions. Briefly, lipofectamine and siRNAs were diluted into
OptiMEM medium (Invitrogen). Diluted lipofectamine
lipids were mixed with diluted siRNAs and the mixture was
incubated for 30 minutes at room temperature for complex
formation. Mixtures were further diluted in OptiMEM and
added to each well such that the final concentration of siR-
NAs was 80 nM. Cells were harvested and assayed 24 hours
after transfection. Negative controls included untransfected
cells, lipid alone, and scrambled siRNA (Santa Cruz).
(2) The siLentGene U6 Cassette RNA Interference System
(Promega). Specific TRPV4 and scrambled sequences were
selected using the Promega design tool. U6 expression
cassettes were constructed following the manufacturers
instructions. Transfection of the U6 DNA expression cas-
settes was performed using siLentGene transfection reagent
(Promega) such that the final concentration of cassettes was
160 ng/mL. In order to localise transfected cells, cells were
cotransfected with RFP (pDsRed2-C1). Cells were harvested
and assayed 72 hours after transfection. Negative controls
included untransfected cells, lipid alone, RFP alone, and
a scrambled siRNA. In each case, TRPV4 knockdown was
confirmed by Western blot analysis as described above.
2.6. Single-Cell Microfluorimetry. HCD cells seeded and
grown overnight on APES-coated coverslips were loaded for
30 minutes at 37◦C with 2.5 μM of the Ca2+ fluorophore
Fura-2/AM (Sigma, UK). Coverslips were washed and placed
in a steel chamber, the volume of which was approximately
500 μL. A single 22mm coverslip formed the base of the
chamber, which was mounted into a heating platform on the
stage of an Axiovert 200 Research Inverted microscope (Carl
Zeiss Ltd., Welwyn Garden City, UK). All experiments were
carried out at 37◦C using unsupplemented DMEM/Hams F-
12 as the standard extracellular medium. Cells were illumi-
nated alternatively at 340 nm and 380 nm using a Metafluor
imaging workbench (Universal Imaging Corp Ltd., Marlow,
Bucks, UK). Emitted light was filtered using a 510 nm long-
pass barrier filter and detected using a Cool Snap HQ
CCD camera (Roper Scientific). Changes in the emission
intensity of Fura-2 expressed as a ratio of dual excitation were
used as an indicator of changes in [Ca2+]i using established
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Figure 1: Expression of TRPV4 mRNA and protein in HCD-cells.
(a) and (c) represent RT-PCR analysis using primers specific for
human TRPV4 and SGK, respectively. PCR products of 618 bp and
699 bp were observed in three RNA preparations (1, 2, and 3)
corresponding to mRNA expression for TRPV4 and SGK in HCD
cells. Negative controls included both water and samples in which
AMV enzyme had been omitted from the reverse transcription
reaction (data not shown).Western blot analyses of HCD cell lysates
((b) and (d) 5 μg protein/lane) using an antibody against human
TRPV4 and SGK confirmed the presence of the protein. A protein
band of approximately 120KDa (TRPV4) and 50KDa was detected.
Controls included TRPV4 and SGK antibody preabsorbed with a
100-fold excess of immunizing peptide (data not shown).
procedures. For Ca2+ free experiments cells were bathed
in calcium-free media supplemented with 1mM EGTA. To
assess the contribution made by intercellular calcium stores
HCD cells were bathed in Ca2+-free media following a
60 minute preincubation with thapsigargin (1 μM). Cells
were then subject to touch evoked stimulation and [Ca2+]i
levels recorded. Data was collected at 3-second intervals for
multiple regions of interest in any one field of view. All
records have been corrected for background fluorescence
(determined from cell-free coverslip).
2.7. Mechanical Stimulation of HCD Cells. Individual cells
within a cluster (6–12 cells/cluster) of Fura-2-loaded cells
were stimulated via touch using a femtotip electrode delivery
system (Eppendorf, Hamburg, Germany). Maintained Fura-
2 fluorescence confirmed integrity of the cell membrane.
2.8. Analysis. Autoradiographs were quantified by densito-
metry using TotalLab 2003 (NonLinear Dynamics, Durham,
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Figure 2: Changes in [Ca2+]i inHCD-cells evoked bymechanical stimulation. In the presence of extracellular calcium (a control), mechanical
stimulation of an individual cell, within a cluster, elicits an increase in [Ca2+]i. The rise in [Ca2+]i rapidly propagates into coupled cells.
Removal of extracellular calcium (b) reduces the basal-to-peak change in mechanically evoked [Ca2+]i, but does not negate the response.
Depletion of Ca2+ stores via preincubation of the Ca2+-ATPase inhibitor, thapsigargin (Tg 1 μM; 30min, (c) in the absence of extracellular
calcium, completely prevents mechanically evoked changes in [Ca2+]i. (d) shows mean basal-to-peak data from several experiments (n =
4) and indicates a role for both intra- and extracellular calcium in mediating mechanically evoked Ca2+-signalling in HCD-cells. Data is
represented as an estimated change in [Ca2+]i recorded as a ratio of 340/380 nm excitation for fura-2. Statistical analysis ((d); P < 0.01
control versus Ca2+-free and P < 0.001 control versus Ca2+-free + Tg).
NC, USA). Where data was quantified, the nonstimulated,
low-glucose control condition was normalized to 100%
and data from all other experimental conditions compared
to this. Statistical analysis of data was performed using a
one-way ANOVA test with a Tukey’s multiple-comparison
posttest. Data are expressed as mean± SEM, and “n” denotes
the number of experiments. Probability (P) < 0.05 was taken
to signify statistical significance.
3. Results
3.1. Expression of TRPV4 and SGK1 in HCD Cells. Studies
confirmed the presence of both TRPV4 and SGK1 mRNA
and protein expression in HCD cells. RT-PCR analysis of
three RNA preparations from HCD cells revealed PCR
products representative of TRPV4 (Figure 1(a)) and SGK1
(Figure 1(c)) mRNAs, respectively. To confirm that all sets
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Figure 3: The eﬀect of glucose on TRPV4 and SGK1 protein expressions in HCD cells. HCD-cells were incubated in 5mM and 25mM
glucose for 48 hours. (a) Representative Western blot analysis using an anti-TRPV4 antibody; (c) analysis of changes in TRPV4 protein
expression. Results represent mean ± SEM; n = 4; ∗∗P < 0.01. (b) Representative Western blot analysis using an anti-SGK antibody; (d)
analysis of changes in SGK protein expression. Results represent mean ± SEM; n = 4; ∗∗P < 0.01.
of mRNA were appropriately translated, protein expression
was determined by Western blotting (Figures 1(b) and
1(d)). Western blot analyses revealed bands at approximately
120 kDa and 50 kDa, representatives of those expected for
TRPV4 and SGK, respectively.
3.2. Touch-Evoked Changes in [Ca2+]i in HCD Cells. Physical
stimulation of a single HCD cell evoked an increase in
cytosolic calcium (Figure 2(a)). The response was rapid in
onset but transient, with [Ca2+]i returning to basal levels
within 60± 10 sec following the initial stimulation and with-
out removal of the stimulating electrode. The rapid transmis-
sion of a [Ca2+]i signal away from the point of stimulation
illustrates cooperativity between HCD-cells and is indicative
of the high degree of cell-to-cell communication previously
demonstrated [12] for these cells (data representative of 5
separate experiments). To examine the role of Ca2+ influx in
mediating touch evoked changes in [Ca2+]i, cells were bathed
in calcium-free media (+EGTA; 1mmol/L). One touch
stimulation of a single cell within a cell cluster still generates
an increase in [Ca2+]i that propagated into neighbouring
cells (Figure 2(b)). However, the basal-to-peak amplitude of
this response (0.21 ± 0.03%) was only 35% of that obtained
in the presence of extracellular calcium (0.60 ± 0.121%; P <
0.01 n = 6 separate experiments; see Figures 2(b) and 2(d)).
Preincubation of cell clusters in Ca2+-free media containing
the Ca2+-ATPase inhibitor thapsigargin (Tg 1 μM) depleted
intracellular stores [15] and completely abolished touch-
evoked changes in [Ca2+]i as expected (Figures 2(c) and
2(d)).
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Figure 4: TRPV4 mediates mechanically evoked changes in [Ca2+]i. (a): western blot analyses of HCD cell lysates (5 μg protein/lane) using
an antibody against human TRPV4 (120 kDa) confirmed siRNA knock-down of TRPV4 expression in lane 4, as compared to control cells
(lane 1, untransfected cells; lane 2, cells transfected with lipid alone; lane 3, cells transfected with scrambled siRNA). Knock-down reduced
TRPV4 expression to approximately 60% of control. Results represent mean± SEM; n = 3; ∗∗P < 0.01. In (b), a single cell within a cluster of
HCD-cells can be identified following co-transfection with anti-TRPV4 siRNA and Red Fluorescent Protein (RFP) using the siLentGene U6
Cassette RNA Interference System (Promega; (b) C). The same cell cluster is visualised as an overlay image following loading with fura-2/AM
((b) D). In (b) F, a nontransfected cell (cell 1) is stimulated mechanically to evoke a rise in [Ca2+]i ((b) H). The RFP-identified cell 2 ((b) D)
fails to evoke a touch-evoked Ca2+-signal ((b) G).
3.3. Glucose-Induced Downregulation in TRPV4 Expression Is
Paralleled by an Upregulation in SGK. To examine the eﬀect
of elevated glucose on TRPV4 and SGK expression, HCD
cells were incubated in high glucose (25mM) for 48 hours
and expression levels of TRPV4 and SGK determined by
western blotting. HCD cells grown under high-glucose con-
ditions exhibited a 54% reduction in TRPV4 expression to
46% ± 6.6% as compared to control (5mM) at 48 hrs (n = 3,
P < 0.01, see Figures 3(a) and 3(c)). Contrary to the eﬀect on
TRPV4, high glucose evoked a 90% ± 16.5% increase in SGK
expression as compared to control at 48 hours, respectively
(Figures 3(b) and 3(d)) (n = 3, P < 0.01). Mannitol
(25mM) was used as a control for the osmotic eﬀects of
high glucose and decreased TRPV4 expression at 48 hr by
approximately 24% ± 1.4% of the glucose-evoked change
seen under identical experimental conditions (P = NS, data
not shown).
3.4. Touch-Evoked Changes in [Ca2+]i AreMediated by TRPV4
Channels. Transiently transfecting cells with siRNA for
TRPV4 significantly reduced TRPV4 protein expression in
HCD-cells to approximately 60% of control as confirmed by
western blot analysis (Figure 4(a) lane 4; representative of
4 separate experiments). Lipofectamine alone or scrambled
siRNA did not reduce TRPV4 expression. Although encour-
aging, the level of downregulation was insuﬃcient to assess
functional responses within the population as a whole. To
overcome this issue, an alternative strategy using a siLent-
Gene Interference system (Promega) allowed cotransfection
with Red Fluorescent Protein and anti-TRPV4, to identify
single-transfected cells within cell clusters (Figure 4(b);
representative of 4 separate experiments). Mechanical stim-
ulation of a nontransfected cell, “cell-1”, (panel F) elicited a
rapid increase in [Ca2+]i (panel H). However, stimulation of
an anti-TRPV4 cell (RFP-tagged “cell-2”; panel C, D and E)
failed to evoke a change in [Ca2+]i (panel G) as previously
observed under control conditions. Transfection with lipid,
RFP-alone or -scrambled siRNA sequences did not alter
responses to touch (data not shown). These data suggest
that knock-down of TRPV4 expression inhibits the ability
of HCD-cells to detect deformation at the cell membrane in
response to either osmotic or mechanical stress.
4. Discussion
Renal epithelial is constantly exposed to fluctuations in
filtrate flow and osmolality. Any changes in cell volume as
a result of these physical stresses must be minimized by
appropriate counter-regulatory mechanisms. Dysregulated
cell volume control will lead to altered cell volume, altered
function, and ultimately tissue damage. During the pro-
gression of renal disease the loss of cells in the nephron is
paralleled by compensatory hypertrophy of the remaining
cells, an eﬀect mediated by a change in sodium transport and
regulated by an increase in cell volume [16]. These changes
can instigate a number of downstream eﬀector mechanisms
that can influence epithelial integrity.
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Figure 5: TRPV4 and SGK1 in the kidney. In healthy nondiabetic individuals, SGK1 is responsible for insertion and retention of ENaCs
into the apical cell membrane, promoting ENaC-mediated Na+ reabsorption from the lumen of the cortical collecting duct (a). SGK1 also
stimulates the Na+,K+-ATPase on the basolateral membrane. TRPV4 receptors will be activated as a counterregulatory mechanism, initiating
a calcium-dependent response, which ensures activation of a regulatory volumes decrease. Through the actions of SGK1 and TRPV4 cell
volume homeostasis is maintained. In a patient with diabetes, however, these counter-regulatory mechanisms may become compromised as
a consequence of glucose-evoked changes in expression (b). SGK expression is increased in response to high glucose. Similarly, glycosuria
may initiate cell shrinkage as water is lost to the lumen. Cell shrinkage is a key trigger for SGK1 activation. This will result in enhanced
SGK1 activity, increased [Na+]i, and enhanced osmotic drag, all of which induce cell swelling. Whilst under healthy conditions this will be
compensated for by a TRPV4-mediated regulatory cell volume decrease; in high glucose, a loss in the expression of this channel (b) will
reduce sensitivity of the cell to deformation at the membrane and [Na+]i will rise.
In the current study, touch was used as a cell-directed
surrogate for osmotic stress in an attempt to confirm and
further delineate a role for TRPV4 in stimulus-response cou-
pling of physical stimuli in the collecting duct. Furthermore,
we have investigated a role for glucose in the regulation of
TRPV4 expression and discussed the implications that these
findings may have on the ability of the collecting duct to
detect and respond to osmotically induced signals under
pathophysiological conditions such as diabetes. In our model
system, we confirm expression of TRPV4 mRNA and protein
and demonstrate that these human-derived cells detect and
transduce touch through a transient rise in cytosolic calcium
[Ca2+]i, a finding consistent with previous data linkingmem-
brane stretch in A6 cells to elevated [Ca2+]i, a key response
in cell volume regulation [17]. The changes in [Ca2+]i were
mediated by both Ca2+-influx and –store release, and the
response was negated by knockingdown the expression of
TRPV4. The response of cells to hypoosmotic challenge
is believed to be a two-step process involving detection
of increased cell volume via increased membrane stretch,
accompanied by alterations in intracellular solute content.
The end goal is restoration of cell volume via a regulatory
volume decrease (RVD), a Ca2+-dependent process [18–20].
The importance of Ca2+ is highlighted by the observation
that cells of the thick ascending limb of Henle’s loop
(TALH) and human cervical cancer cells lose their ability
to regulate cell volume in Ca2+-free media [21]. The origin
of osmotically evoked changes in [Ca2+]i in RVD varies
between cell types and can depend on either Ca2+ influx
alone [8] or have dual dependency on Ca2+ mobilisation
from cytosolic stores [22], where store depletion has been
shown to subsequently activate Ca2+ influx via store operated
entry [20, 21]. Evidence from the current study supports
a role for TRPV4 in regulating cell volume through both
Ca2+ mobilisation and influx pathways. In the absence of
extracellular calcium the basal-to-peak amplitude of touch-
evoked changes in [Ca2+]i was significantly lower than
that evoked by the same stimulus in calcium containing
conditions. Previous studies have suggested that the rise
of [Ca2+]i during cell swelling is a consequence of both
TRPV4-mediated Ca2+ influx [23, 24], and Ca2+-induced
Ca2+ release (CICR) from thapsigargin-sensitive intracellular
stores [17]. Therefore, although Ca2+-influx is not essential
in elicitating a rise in [Ca2+]i, Ca2+ entry accentuates the
amplitude of the response and may be crucial in initiation
of RVD [17, 25].
In diabetes, increases in circulating glucose often spill
over into the urine. The resultant osmotic drag increases
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tubular flow within the nephron and increases the formation
of a hyperosmotic urine. These physical changes induce
cell shrinkage of renal epithelial cells and ultimately trigger
activation of those compensatory mechanisms aimed at
restoring cell volume. Activated in response to cell shrinkage,
SGK1 is one of the key regulators of Na+ reabsorption in the
nephron through regulation of the epithelial sodium channel
(ENaC) [14]. Demonstrating elevated levels of expression in
models of diabetic nephropathy with concomitant increased
[Na+]i levels, SGK has been proposed as a potential key
mediator of increased Na+ reabsorption and the subsequent
development of secondary hypertension observed in patients
with diabetic nephropathy [3, 4]. Under nondiabetic healthy
conditions, SGK1 acts to increase ENaC-mediated Na+ and
water reabsorption, instigating a regulatory volume increase
[26] (Figure 5(a)). However, in diabetes, and as confirmed
by the current study, where hyperglycaemia dramatically
increases SGK1 expression, without the intervention of
rapid counter-regulatory mechanisms to alleviate exacer-
bated SGK-mediated Na+ retention, the individual would
be prone to exaggerated sodium retention and secondary
hypertension. TRPV4-mediated increases in [Ca2+]i have
been shown to initiate a cell regulatory volume decrease
and thus counterbalance the hyperosmotic-inducted eﬀects
of SGK. However, in the current study we show that high
glucose dramatically downregulates TRPV4 expression. Loss
in TRPV4 will compromise the necessary counter-regulatory
volume decrease essential to the cell if able to respond to a
state of cell swelling induced by glucose-evoked increases in
SGK1 expression (Figure 5(b)). In the present study, siRNA
knockdown of TRPV4 expression negated touch-evoked
changes in [Ca2+]i further confirming the pivotal role for
TRPV4 channels in detection and transduction of osmotic-
like signals and demonstrating the potential consequences of
a loss in expression over cell integrity and function under
pathophysiological conditions such as diabetes.
In conclusion, the current study suggests that touch-
evoked stimulation of HCD cells initiates a rise in [Ca2+]i
through TRPV4 channel stimulus-response coupling to
thapsigargin-sensitive intracellular store release and Ca2+
entry; changes previously shown to be key mediators in
instigation of cell volume regulatory mechanisms. As already
discussed, cell volume regulation is critical to the overall
integrity of both the cell and nephron. Inability therefore
to respond appropriately to osmotic stimuli could have
detrimental consequences for fluid and electrolyte balance in
the kidney and may ultimately contribute to various renal
pathologies, including diabetic nephropathy and end-stage
renal disease.
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